Mylan, Sandoz Defeat Teva Patent Lawsuit Over Copaxone

Mylan Inc. and Sandoz AG won the dismissal of lawsuits by Teva Pharmaceutical Industries Ltd. that claimed the drug companies infringed its patents for a medicine used to treat multiple sclerosis.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.